Enzalutamide

Spécifications

915087-33-1Numéro CAS

805-022-1Numéro CE

4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamideNom IUPAC

C21H16F4N4O2SFormule chimique

464.4 g/molMasse molaire

Enzalutamide; 915087-33-1; MDV3100; MDV-3100; 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide; MDV 3100; XTANDI; Enzalutamida; 93T0T9GKNU; 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide; CHEBI:68534; DTXSID10912307; 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide; 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide; Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-; Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; enzalutamidum; 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl)-2-fluoro-N-methylbenzamide; RefChem:58964; ASP9785; L02BB04; DTXCID301341329; 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-benzamide; 805-022-1; Enzalutamide (MDV3100); MDV3100 (Enzalutamide); C21H16F4N4O2S; MDV 3100-d3; MFCD14155804; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; MDV 3100 (Enzalutamide); 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide; Enzalutamide [USAN]; Enzalutamide [USAN:INN]; UNII-93T0T9GKNU; Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; Enzalutamide; MDV 3100; Xtandi; Xtandi (TN); Enzalutamide (Standard); ENZALUTAMIDE [MI]; Enzalutamide; MDV3100; MDV3100(Enzalutamide); Enzalutamide (JAN/USAN); ENZALUTAMIDE [INN]; ENZALUTAMIDE [JAN]; ENZALUTAMIDE [VANDF]; Enzalutamide (MDV3100)?; MLS006010067; ENZALUTAMIDE [WHO-DD]; SCHEMBL189749; GTPL6812; orb1223661; orb1301219; CHEMBL1082407; SCHEMBL29352764; EX-A046; ENZALUTAMIDE [ORANGE BOOK]; HMS3654L07; HMS3672M13; HMS3744C19; HMS5079M21; NC-54; ASP-9785; THC33182; BDBM50425732; EBC-17120; HY-70002R; NSC755605; NSC766085; s1250; AKOS015851022; CCG-264879; CS-0317; DB08899; FC65076; NSC-755605; NSC-766085; SB20413; NCGC00263120-01; NCGC00263120-07; AC-26924; AS-17047; BP-45823; HY-70002; MDV3100, 95%; SMR004701227; NS00040668; SW219288-1; T6002; D10218; AB01565849_02; EN300-20605530; F079389; F575061; SR-01000941580; Q1996756; SR-01000941580-1; BRD-K56851771-001-01-9; BRD-K56851771-001-06-8; 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide, Enzalutamide ImpuritySynonymes